Aaron Koenig, MD

Dr Koenig currently serves as Chief Medical Officer for Delix Therapeutics, is a diplomate of the American Board of Psychiatry and Neurology, and retains active board certification in adult and geriatric psychiatry.

Prior to joining Delix, Dr Koenig was vice president of Early Medical Science (Clinical Development) at Sage Therapeutics. During his time at Sage, Dr Koenig was responsible for conceptualizing, designing, and executing on Sage’s clinical-stage neuropsychiatry programs, from first-in-human to pivotal Ph2b studies. In this capacity, Dr Koenig oversaw assets within Sage’s early and mid-stage neuropsychiatry portfolio and managed a team of physicians and clinical scientists to ensure seamless execution of high-priority clinical development programs. Prior to Sage, Dr Koenig served as an associate medical director in the Alzheimer’s Disease Research Unit at Biogen.